This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Istfan, N. W. Articles by Blackburn, G. L. Search for Related Content PubMed PubMed Citation Articles by Istfan, N. W. Articles by Blackburn, G. L.

Hypertension, Vol 19, 385-392, Copyright © 1992 by American Heart Association

ARTICLES

Insulin resistance versus insulin secretion in the hypertension of obesity

NW Istfan, CS Plaisted, BR Bistrian and GL Blackburn
Cancer Research Institute, New England Deaconess Hospital, Boston, MA 02215.

We measured the degree of association between obesity, blood pressure, insulin resistance, and insulin secretion in 72 male and female obese hypertensive, obese nonhypertensive, and normal weight control subjects. Baseline weight, body mass index, percent body fat, waist/hip ratio, and systolic and diastolic blood pressures were obtained. Insulin sensitivity was assessed according to Bergman's minimal model. Twelve-hour urinary c-peptide was measured after a standard liquid meal. Insulin action was inversely associated with blood pressure status, obesity status, and age. Meal-stimulated c-peptide excretion significantly correlated with systolic blood pressure and percent fat but not with body mass index or age. Multivariate regression analysis indicated that, of the measures of body composition, percent fat and waist/hip ratio had the strongest correlation with insulin action either alone or in combination with c-peptide excretion. Obese hypertensive patients had an index of insulin action (10(-4).min- 1/[microunits/ml]) of 1.34 +/- 0.19, which was significantly (p less than 0.003) lower than in the obese nonhypertensive patients (index, 2.26 +/- 0.10) or the nonobese subjects (index, 5.41 +/- 0.26, p less than 0.001). Meal-stimulated c-peptide excretion (nmol/kg lean body mass) was increased only in the obese hypertensive group (0.32 +/- 0.01) and was significantly higher (p less than 0.001) than in the obese nonhypertensive (0.16 +/- 0.01) or the nonobese subjects (0.14 +/- 0.01). These results support the hypothesis that abnormalities in blood pressure regulation, insulin-stimulated glucose uptake, and insulin secretion coexist.

This article has been cited by other articles:

				J. He, M. J. Klag, B. Caballero, L. J. Appel, J. Charleston, and P. K. Whelton Plasma Insulin Levels and Incidence of Hypertension in African Americans and Whites Arch Intern Med, March 8, 1999; 159(5): 498 - 503. [Abstract] [Full Text] [PDF]

				J. R. Sowers Obesity and cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1821 - 1825. [Abstract] [Full Text] [PDF]

				K. T. Stepniakowski, G. Lu, R. K. Davda, and B. M. Egan Fatty Acids Augment Endothelium-Dependent Dilation in Hand Veins by a Cyclooxygenase-Dependent Mechanism Hypertension, December 1, 1997; 30(6): 1634 - 1639. [Abstract] [Full Text]

				B. M. Egan, M. M.I. Hennes, K. T. Stepniakowski, I. M. O'Shaughnessy, A. H. Kissebah, and T. L. Goodfriend Obesity Hypertension Is Related More to Insulin's Fatty Acid Than Glucose Action Hypertension, March 1, 1996; 27(3): 723 - 728. [Abstract] [Full Text]

				S. Gudbjornsdottir, P. Lonnroth, Y. B. Sverrisdottir, B. G. Wallin, and M. Elam Sympathetic Nerve Activity and Insulin in Obese Normotensive and Hypertensive Men Hypertension, February 1, 1996; 27(2): 276 - 280. [Abstract] [Full Text]

				I. M. O'Shaughnessy, T. J. Myers, K. Stepniakowski, P. Nazzaro, T. M. Kelly, R. G. Hoffmann, B. M. Egan, and A. H. Kissebah Glucose Metabolism in Abdominally Obese Hypertensive and Normotensive Subjects Hypertension, July 1, 1995; 26(1): 186 - 192. [Abstract] [Full Text]

				G. L. Blackburn and E. C. L. Borrazzo Weight Cycling JAMA, April 5, 1995; 273(13): 998 - 998. [Abstract] [PDF]